Antifungal susceptibility testing of Candida isolates from the Candida surveillance study.
about
Quantitative and qualitative analysis of the antifungal activity of allicin alone and in combination with antifungal drugsSurveillance of the prevalence, antibiotic susceptibility, and genotypic characterization of invasive candidiasis in a teaching hospital in China between 2006 to 2011.Candidemia in patients with prolonged fever in Kashan, Iran.Role of FKS Mutations in Candida glabrata: MIC values, echinocandin resistance, and multidrug resistance.Species identification and antifungal susceptibility testing of Candida bloodstream isolates from population-based surveillance studies in two U.S. cities from 2008 to 2011.Candida glabrata perinephric abscess.Susceptibility of Candida spp. isolated from blood cultures as evaluated using the M27-A3 and new M27-S4 approved breakpointsEffect of pH on in vitro susceptibility of Candida glabrata and Candida albicans to 11 antifungal agents and implications for clinical use.Candidacidal Activity of Selected Ceragenins and Human Cathelicidin LL-37 in Experimental Settings Mimicking Infection Sites.Epidemiology of invasive fungal infections in the intensive care unit: results of a multicenter Italian survey (AURORA Project)Propensity Score Analysis of the Role of Initial Antifungal Therapy in the Outcome of Candida glabrata Bloodstream Infections.In Vitro Activities of Six Antifungal Drugs Against Candida glabrata Isolates: An Emerging Pathogen.Clinical characteristics of Turkish women with Candida krusei vaginitis and antifungal susceptibility of the C. krusei isolates.Proteomic Analysis of Intracellular and Membrane Proteins From Voriconazole-Resistant Candida glabrataSynergistic effect of the flavonoid catechin, quercetin, or epigallocatechin gallate with fluconazole induces apoptosis in Candida tropicalis resistant to fluconazole.Genetic diversity of the Hwp1 gene and HIS3, EF3, CDC3 microsatellites and antifungal susceptibility profiles of Candida albicans isolates from Yaoundé HIV-infected patients.Probiotic yeast Saccharomyces boulardii (nom. nud.) modulates adhesive properties of Candida glabrata.In Vitro Activity of Caspofungin Against Fluconazole-Resistant Candida Species Isolated From Clinical Samples in Iran.Invasive candidosis: contrasting the perceptions of infectious disease physicians and intensive care physicians.Mechanisms involved in the triggering of neutrophil extracellular traps (NETs) by Candida glabrata during planktonic and biofilm growth.Candida lusitaniae MICs to the echinocandins are elevated but FKS-mediated resistance is rare.In vitro antifungal activity of Indian liposomal amphotericin B against clinical isolates of emerging species of yeast and moulds, and its comparison with amphotericin B deoxycholate, voriconazole, itraconazole and fluconazole.Evaluation of antifungal susceptibility testing with microdilution and Etest methods of Candida blood isolates.Species distribution and in vitro fluconazole susceptibility of clinical Candida isolates in a Brazilian tertiary-care hospital over a 3-year period.Vulvovaginal candidiasis: species distribution of Candida and their antifungal susceptibility pattern.Echinocandin-Induced Microevolution of Candida parapsilosis Influences Virulence and Abiotic Stress Tolerance
P2860
Q28484112-C9D225AB-D67E-48FD-95CD-FAD27DEFB431Q30658189-4D620603-E6EC-4488-9C17-A5C8C4F6D3B6Q33851292-FDE1698A-0C73-4D75-BBAD-9E2849E63F4CQ34058099-07B6A018-5A91-49E8-8253-09A3DAB5238BQ34372192-C51FF59B-8042-4DA5-8D8E-2B272DB1D7F8Q34666621-DC2BF9C8-4E92-4C2F-9F61-5B6E671B4E56Q34977249-481F2C3F-FE39-4775-BA95-E5A7AAB19C10Q35806236-804DAC1C-63D8-4E41-B546-DF5A4B8D7E15Q36055572-C50AE153-AC11-4467-A691-7D1CC491BDB6Q36898053-E8456593-0ED0-4FB2-9849-1495A07C4EA8Q36933437-E0B09E7D-179A-4418-AAF6-49888EE8A94CQ37160845-B63F8199-88BC-454F-BC8F-9A7250B7DF8EQ37417391-BEDB7A8A-DA2E-40FD-AE9F-C580F0E493A3Q37579679-FF7A74CE-4BFA-41F6-9E4B-3B943762BB4BQ37643678-F0920C4B-7FAE-4CD9-8BBB-09BCB848EB0EQ40505796-7C5243C0-6539-4B08-B3C8-953521073839Q40649724-B29EF905-B72D-4D99-B5C1-FDFCC052CB65Q41024436-2B4FA3D3-3884-4ABD-B485-D57CB22258B5Q42252984-698119A9-8D35-4F8B-B77B-53DB13AA9442Q42376003-FF8ABFEA-DB97-4BE9-ADFD-59320CDA9B75Q46660786-E7D032AE-C3AD-4A65-9571-2E0000BA68ACQ50950336-A1A5A728-1201-43F7-B61A-1D9AF609C5FAQ51175703-8BB81CF5-0168-4C16-BF1D-FB509686D1A5Q54342210-BD1BFE41-CC9A-410E-BD50-A6D3228C8294Q55340243-EA463BB0-CB05-45F9-987A-093DD4DA3E92Q59136029-5AD28C58-60B3-4790-8CB0-2479D6F3CCD1
P2860
Antifungal susceptibility testing of Candida isolates from the Candida surveillance study.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Antifungal susceptibility test ...... he Candida surveillance study.
@en
Antifungal susceptibility test ...... he Candida surveillance study.
@nl
type
label
Antifungal susceptibility test ...... he Candida surveillance study.
@en
Antifungal susceptibility test ...... he Candida surveillance study.
@nl
prefLabel
Antifungal susceptibility test ...... he Candida surveillance study.
@en
Antifungal susceptibility test ...... he Candida surveillance study.
@nl
P2093
P2860
P356
P1476
Antifungal susceptibility test ...... he Candida surveillance study.
@en
P2093
Candida Surveillance Study Investigators
G Marshall Lyon
Sulaiman Karatela
Susan Sunay
Yaffa Adiri
P2860
P304
P356
10.1128/JCM.02363-09
P407
P577
2010-02-03T00:00:00Z